Your Guide to Idiopathic & Heritable Pulmonary Arterial Hypertension (IPAH/HPAH)
At a Glance
Idiopathic and Heritable Pulmonary Arterial Hypertension (IPAH/HPAH) are rare diseases involving vascular remodeling in the lungs. Modern treatments, including upfront combination therapies and breakthrough disease-modifying drugs, offer patients a brighter outlook and proactive management.
Welcome to your resource guide for Idiopathic and Heritable Pulmonary Arterial Hypertension (IPAH and HPAH). A rare disease diagnosis can feel isolating and overwhelming, but you are not alone. Research and treatments for PAH are advancing rapidly, shifting this condition into a new era of disease-modifying therapies and proactive management.
This guide was built specifically for you—the patient. It translates the latest 2022 ESC/ERS medical guidelines, complex genetic biology, and standard-of-care treatments into empowering, actionable information. Our goal is not to give you medical advice, but to give you the knowledge you need to sit at the table with your doctors as an informed partner in your care.
How to Use This Guide
We recommend reading these pages in order to build your understanding step-by-step:
Validation & Orientation: Understanding an IPAH/HPAH Diagnosis
Recently diagnosed with idiopathic or heritable pulmonary arterial hypertension (IPAH/HPAH)? Learn about your diagnosis, treatment outlook, and next steps.
Biology & Genetics: How IPAH/HPAH Works in Your Body
Learn how Idiopathic and Heritable Pulmonary Arterial Hypertension (IPAH/HPAH) work in the body. Understand vascular remodeling, BMPR2 genes, and family risks.
Diagnostic Criteria and Ruling Out Look-Alikes
Learn the diagnostic criteria for pulmonary arterial hypertension (PAH). Understand why right heart catheterization is required to rule out look-alike conditions.
Treatment Strategy: Standard of Care and New Breakthroughs
Learn about standard PAH treatments like upfront combination therapy, new breakthroughs like sotatercept (Winrevair), and when prostacyclin pumps are needed.
Risk Stratification & Monitoring: Tracking Your Progress
Learn how doctors monitor Pulmonary Arterial Hypertension (PAH) using the 4-strata risk model, 6-minute walk tests, and NT-proBNP levels to guide treatment.
Take your time. Read one section, write down your questions, and bring them to your next appointment. Knowledge is your most powerful tool in navigating this journey.
Common questions in this guide
What is the difference between idiopathic and heritable PAH?
How is pulmonary arterial hypertension diagnosed?
What are the current treatments for IPAH and HPAH?
How will my doctor monitor my PAH over time?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What specific type of PAH do I have, and are we certain it isn't related to another underlying condition?
- 2.Who is the primary contact on my care team if I experience a sudden worsening of symptoms?
- 3.How often should we meet to evaluate if my current treatment plan is working?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
This guide to idiopathic and heritable pulmonary arterial hypertension is for informational purposes only. It does not replace professional medical advice, diagnosis, or treatment from your pulmonologist or cardiologist.
Get notified when new evidence is published on Idiopathic/heritable pulmonary arterial hypertension.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.